Healthcare
Dario Expands Provider-Backed Cardiometabolic Platform with New Women's Health and Sleep Solutions Aligning with Client Demand
DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced it has further expanded its provider-backed cardiometabolic platform with the launch of Dario Women™ and Dario Sleep™. The two new programs address important drivers of cardiometabolic health through an integrated care experience combining AI-powered engagement, behavioral support and access to licensed h
About this update from Dariohealth Corp.
New programs, expected to begin revenue contribution Q4 2026, extend Dario's integrated healthcare platform into two high-impact clinical categories while advancing execution of the Company's provider-backed care strategy AI-enabled programs combine digital engagement, human behavioral coaching and clinical care to improve outcomes while expanding Dario's participation in reimbursement-driven healthcare services NEW YORK, Aug. 4, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced it has further expanded its provider-backed cardiometabolic platform with the launch of Dario Women™ and Dario Sleep™. The two new programs address important drivers of cardiometabolic health through an integrated care experience combining AI-powered engagement, behavioral support and access to licensed healthcare providers. The new offerings come as demand from large enterprise payers for multi-condition solutions continues to rise, and single point offerings are phased out. While increasing the indications supported by its platform, Dario has further expanded into provider-backed care to broaden participation in reimbursement-driven healthcare services. Both Dario Women™ and Dario Sleep™ are expected to roll out to the Company's Fortune 500 and other clients in Fall 2026. Recurring revenue contribution per engaged member per month for the digital health platform is expected to commence in the fourth quarter of 2026, with revenue from the provider-backed care services anticipated at the end of 2026 and into the beginning of 2027. The new programs are expected to expand revenue opportunities across Dario's existing enterprise customer base by allowing employers and health plans to address additional high-cost clinical needs through the same integrated platform. "Dario continues to execute on our strategy of integrating provider-backed care throughout our expanding chronic condition platform," said Erez Raphael, Chief Executive Officer of Dario. "Women's health and sleep represent significant opportunities to improve cardiometabolic outcomes while expanding the value we deliver to employers, health plans and members. As we continue adding clinical capabilities to our platform, we strengthen our ability to supp...